The upward trend could come to support LifePoint Hospitals in the coming sessions.

The company is under-valued with an EV/Sales ratio of 1.04x for 2013 (sector : 1.65x).

Following a bullish wave, the stock now shows a slight decline that led it towards the USD 47.3 medium-term support, corresponding to the 100-day moving average. On this level, remobilization of buyer flows would allow an uptrend in the medium and long term.

The USD 47.3 area could be a basis for a purchase to target USD 52. A stop loss will be fixed below USD 47.3.